Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
New Implant Enables 3-Year-Old Boy to Hear for First Time
A 3-year-old boy last month became the first child in the United
States to receive an auditory brain stem implant.
The first time that Grayson Clamp heard sound was recorded on
video. His mouth opens wide as he points to the person in front of
him who is speaking,
Grayson was born without a cochlear nerve, which carries sound
waves to the brain. He was fitted for a cochlear implant at an
early age but the device didn't help.
Until now, auditory brain stem implants in the U.S. have been
limited to adults. When Grayson's parents learned about a clinical
trial for children at the UNC Hospitals in Chapel Hill, N.C., they
signed the youngster up.
"He's sound aware, but we don't know what exactly he hears," said surgeon Dr. Craig Buchman, CNNreported. "We're relying on the plasticity of brain to start to sort this out."
The Food and Drug Administration has approved the implant for
only 10 children.
USDA OKs Label for Meat from Animals Not Given Gene-Modified
A label for meat from animals that have not been given
genetically-modified feed has been approved by the U.S. Department
The label is the first of its kind and says that meat certified
by the Non-GMO Project is from livestock that never ate
genetically-modified ingredients such as soy, corn and alfalfa,
The New York Timesreported.
This "allows companies to demonstrate on their labels that they
meet a third-party certifying organization's standards, provided
that the third-party organization and the company can show that the
claims are truthful, accurate and not misleading," USDA spokeswoman
Cathy Cochran said in a statement.
She said the approval of the label was not an indication of "any
new policy regarding non-G.E. or non-G.M.O. products,"
Flu Shot Approved for Those With Egg Allergies
A new flu vaccine that is produced without eggs was approved by
a federal advisory panel Thursday.
The unanimous vote of recommendation from the Advisory Committee
on Immunization Practices will give adults with egg allergies a way
to protect themselves in the coming flu season.
Called FluBlock, the vaccine was licensed by the U.S. Food and
Drug Administration last January.
Using an insect virus and recombinant DNA technology, FluBlock
is made by Protein Sciences Corp. of Meriden, Conn. The method used
to produce the vaccine is also used in the manufacture of other
vaccines, according to the U.S. Centers for Disease Control and
Although officials do not know how many people might be allergic
to eggs, an estimated one in every 66 children has the allergy.
However, the new vaccine is currently only approved for use in
people aged 18 to 49, the CDC added.
Side effects with FluBlock are similar to those seen with other
flu vaccines, and include pain at the injection site, headache,
fatigue and muscle aches, the CDC said.
FluBlock has a shorter shelf life than other flu vaccines, and
doctors should check the expiration date before giving it to
patients, the CDC said.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.